Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab
Update: 2020-08-06
Description
In this podcast, Dr. Paul Studenic speaks to Dr. Sofia Ramiro and Prof. Robert Landewé both engaged in clinical work in the Zuyderland Medical Center in the south of the Netherlands about their clinical study evaluating systemic glucocorticoids and Il-6 blockade as second-line treatment for COVID-19-associated cytokine storm syndrome. They tell the story of the set-up of a peculiar trial using historical patients treated with supportive care as controls to the ‘experimental’ treatment strategy during these unprecedented times of March and April 2020.
Link to article: https://ard.bmj.com/content/79/9/1143
Link to article: https://ard.bmj.com/content/79/9/1143
Link to EULAR press release: https://www.eular.org/sysModules/obxContent/files/www.eular.2015/1_42291DEB-50E5-49AE-5726D0FAAA83A7D4/eular_glucocorticoids_and_il_6_receptor_can_reduce_covid19_css_related_hospital_mortality_(002).pdf
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
